Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management
- PMID: 38319876
- DOI: 10.1056/EVIDx2200180
Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management
Abstract
In the Original Article, "Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management," originally published February 3, 2022 (DOI: 10.1056/EVIDoa2100028), under the Results section, in the first paragraph titled "Prespecified Secondary Outcomes" where the text reads "…(risk difference, 13.4; 95% CI, -∞ to -3.9)" should have read "…(risk difference, -13.4; 95% CI, -∞ to -3.9)". A corrected version of the article has been posted at evidence.nejm.org.
Erratum for
-
Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management.NEJM Evid. 2022 Mar;1(3):10.1056/evidoa2100028. doi: 10.1056/evidoa2100028. Epub 2022 Feb 3. NEJM Evid. 2022. PMID: 35434725 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources